Clinical trials
Completed Triple Negative Breast Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Merck Sharp & Dohme LLC | 2 |
| AbbVie | 1 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Cantargia AB | 1 |
| Exelixis | 1 |
| Genentech, Inc. | 1 |
| Institut de Recherches Internationales Servier | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Pancreatic Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Melanoma | 3 |
| Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Cholangiocarcinoma | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.